Zubovic Ema, Skolnick Gary B, AuBuchon Jacob D, Waters Erika A, Snyder-Warwick Alison K, Patel Kamlesh B
Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Cleft Palate Craniofac J. 2023 Jul;60(7):833-842. doi: 10.1177/10556656221083082. Epub 2022 Feb 28.
To critically analyze pediatric opioid prescription patterns after cleft and craniosynostosis repairs.
Observational study 1) retrospectively reviewing pediatric opioid prescriptions from July 2018 to June 2019 and 2) prospectively surveying patients about actual opioid use from August 2019 to February 2020.
Academic tertiary care pediatric hospital.
133 pediatric patients undergoing cleft lip and/or palate or craniosynostosis repairs. Prospective surveys were offered at postoperative visits; 45 of 69 eligible patients were enrolled.
None.
Opioid doses prescribed at discharge and actual home opioid use.
90 patients with cleft lip and/or palate and 43 patients with craniosynostosis were included. Median prescribed opioid doses were 10.3 for cleft lip and/or palate procedures (range 0-75), and 14.3 for craniosynostosis repairs (range 0-50). In patients with cleft lip and/or palate, there was a negative correlation between age at surgery and prescribed opioid doses ( = -0.228, = 0.031). 45 patients completed surveys of home opioid use. No patients used more than 10 doses. Forty percent used no opioids at home, 33% used 1 to 2 doses, 18% used 3 to 5 doses, and 9% used 6 to 10 doses.
Opioid prescriptions vary widely after common craniofacial procedures. Younger patients with cleft lip and/or palate may be more likely to be prescribed more doses. Actual home opioid use is less than prescribed amounts, with most patients using five or fewer doses. A prescribing guideline is proposed.
批判性分析唇腭裂及颅缝早闭修复术后儿童阿片类药物的处方模式。
观察性研究,1)回顾性分析2018年7月至2019年6月期间儿童阿片类药物处方,2)前瞻性调查2019年8月至2020年2月期间患者实际阿片类药物使用情况。
学术性三级护理儿童医院。
133例接受唇裂和/或腭裂或颅缝早闭修复术的儿科患者。术后随访时进行前瞻性调查;69例符合条件的患者中有45例入选。
无。
出院时开具的阿片类药物剂量及患者在家实际使用的阿片类药物情况。
纳入90例唇裂和/或腭裂患者及43例颅缝早闭患者。唇裂和/或腭裂手术的阿片类药物处方剂量中位数为10.3(范围0 - 75),颅缝早闭修复术为14.3(范围0 - 50)。唇裂和/或腭裂患者中,手术年龄与处方阿片类药物剂量呈负相关(r = -0.228,P = 0.031)。45例患者完成了家庭阿片类药物使用情况调查。没有患者使用超过10剂。40%的患者在家未使用阿片类药物,33%使用1至2剂,18%使用3至5剂,9%使用6至10剂。
常见颅面手术后阿片类药物处方差异很大。年龄较小的唇裂和/或腭裂患者可能更易被处方更多剂量。患者在家实际使用的阿片类药物少于处方量,大多数患者使用五剂或更少。提出了一项处方指南。